ATRA - Atara Biotherapeutics, Inc.
4.9
-0.280 -5.714%
Share volume: 34,589
Last Updated: 04-23-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.18
-0.28
-0.05%
Summary score
42%
Profitability
53%
Dept financing
43%
Liquidity
48%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-12.64%
Return on sales
-3504.37%
Return on invested capital
0%
Total debt ratio
141.53%
Debt ratio change over timeo
-0.9%
Current Ratio
1.88%
Quick Ratio
1.31%
Cash Position Ratio
0.61%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
11.63%
Return on sales
-51.62%
Return on invested capital
0%
Total debt ratio
223.86%
Debt ratio change over timeo
0%
Current Ratio
1.03%
Quick Ratio
1.03%
Cash Position Ratio
0.58%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-12.91%
Return on sales
-160.69%
Return on invested capital
0%
Total debt ratio
290.27%
Debt ratio change over time
0%
Current Ratio
0.82%
Quick Ratio
0.82%
Cash Position Ratio
0.57%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
-105.31%
Return on sales
-387.88%
Return on invested capital
0%
Total debt ratio
-89.61%
Debt ratio change over time
-0.9%
Current Ratio
-0.26%
Quick Ratio
0%
Cash Position Ratio
-0.76%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ATRA | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 5.97% | 8.91% |
| Return on assets | -12.64% | 2.97% | 3.34% | 2.04% |
| Return on sales | -3504.37% | 27.71% | 27.82% | 21.49% |
| Return on invested capital | 0% | 0% | 3.51% | 10.25% |
| Profitability | 0% | 47% | 75% | 85% |
| Total debt ratio | 141.53% | 93.27% | 65.75% | 43.64% |
| Debt ratio change over time | -0.9% | 14.34% | 187.33% | 9.75% |
| Dept financing | 25% | 18% | 37% | 9% |
| Current Ratio | 1.03% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 1.03% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 0.58% | 0.39% | 0.58% | 0.86% |
| Liquididy | 60% | 63% | 50% | 73% |
| Short-term ratios | ATRA | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 11.63% | 3.27% | 4.7% | 1.36% |
| Return on sales | -51.62% | 24.35% | 34.09% | 15.11% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 75% | 25% | 35% | 14% |
| Total debt ratio | 223.86% | 91.09% | 63.87% | 38.21% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 10% | 7% | 4% |
| Current Ratio | 1.03% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 1.03% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 0.58% | 0.39% | 0.58% | 0.86% |
| Liquididy | 43% | 38% | 51% | 75% |